Posted on January 6, 2012 by Douglas J. Wood

'Sunshine Act' à la française adopted on 29 December 2011. Healthcare and cosmetics companies will be subject to a tough transparency regulation in France

New French regulations, mirroring similar rules in the United States, place health care and cosmetics companies operating in France with heavy disclosure requirement if they have any pecuniary relationship with researchers, universities, or any other third parties in connection with the marketing of their products. For a full bulletin on this development, please visit our sister blog, the Global Regulatory Enforcement Law Blog.

Tags: ,
Trackbacks (0) Links to blogs that reference this article Trackback URL
http://www.adlawbyrequest.com/admin/trackback/267935
Comments (0) Read through and enter the discussion with the form at the end
Post A Comment / Question Use this form to add a comment to this entry.







Remember personal info?
Send To A Friend Use this form to send this entry to a friend via email.